.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01E_ProteinKinaseInhibitors.L01EJ03_Pacritinib.Pacritinib

Information

name:Pacritinib
ATC code:L01EJ03
route:oral
n-compartments2

Pacritinib is an oral, selective inhibitor of Janus-associated kinases JAK2 and FLT3 used for the treatment of myelofibrosis, particularly in patients with thrombocytopenia. It is approved for use in several countries for adults with intermediate- or high-risk primary or secondary myelofibrosis.

Pharmacokinetics

Population pharmacokinetic parameters reported in adult patients with myelofibrosis, following oral administration as part of clinical development.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos